HCM HUTCHMED (China) Limited

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · hutch-med.com

14.28USD-2.19%Mkt Cap: 2.48B $P/E: 142.801d ago

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and …

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited

$58.68BUSD

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB (publ)

$14.43BUSDP/E 112.9

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporated

$11.17BUSD

RDY

Dr. Reddy's Laboratories Limited

Hims & Hers Health, Inc.

$6.89BUSD

AMRX

Amneal Pharmaceuticals, Inc.

$6.84BUSDP/E 40.1

Key Statistics

Company

Market Cap2.48B USD

Enterprise Value1.27B USD

Revenue (TTM)549.12M USD

Gross Profit212.16M USD

Net Income (TTM)456.91M USD

Revenue/Share3.19 USD

Last Price14.28 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.8K

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)142.80

P/E (Forward)56.32

PEG—

EV/EBITDA-61.90

EV/Revenue2.31

P/S4.62

P/B2.01

EPS (TTM)0.10

EPS (Forward)0.26

52W Range

9.77068% of range16.40

52W High16.40 USD

52W Low9.770 USD

Profitability

Gross Margin38.68%

Oper. Margin0.31%

EBITDA Margin-3.74%

Profit Margin83.30%

ROE36.91%

ROA26.06%

Growth

Revenue Growth0.20%

Earnings Growth-96.50%

Cash Flow & Leverage

Operating CF-64.66M USD

CapEx (TTM)24.15M USD

FCF Margin-3.44%

FCF Yield-0.76%

Net Debt-1.28B USD

Net Debt/EBITDA62.49

Balance Sheet

Debt/Equity0.08

Current Ratio5.64

Quick Ratio5.45

Book Value/Sh7.25 USD

Cash/Share7.92 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.5 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)22.01 USD

Upside (mean)+54.1%

Target Range13.60 USD – 40.40 USD

13.60+54.1% to mean40.40

# Analysts14

Ownership

Shares Out.173.81M

Float105.61M

Insiders0.01%

Institutions2.60%

Short Interest

Short Ratio2.1d

Short % Float0.22%

Short % Out.0.13%

Shares Short230.03K

Short (prev mo.)169.62K

Technical

SMA 5012.87 (+10.9%)

SMA 20013.22 (+8.0%)

Beta0.36

S&P 52W Chg16.45%

Avg Vol (30d)82.13K

Avg Vol (10d)60.60K

Technical Indicators

RSI (14)57.3

MACD0.4552

MACD Signal0.4915

MACD Hist.-0.0363

BB Upper14.96 USD

BB Middle14.01 USD

BB Lower13.05 USD

BB Width13.67%

ATR (14)0.4403 USD

Vol Ratio (20d)0.81x